glp-1/glucagon dual receptor agonist Discovery of Biased Dual-Agonists of Glucagon-Like Peptide 1 and Glucagon Receptors through Mutation of a Conserved Aspartate Oral GLP-1-Based Therapeutics in the
Description
Discussion The crystallized inactive GLP-1R structure is not compatible with the known binding mode of GLP-1 requiring a conformational change of the ECD and a rearrangement of the TMD to enable binding of GLP-1

How quickly do GLP-1s work

BMC Neurosci

According to this study, both hyperglycemia and hypoglycemia in patients with type 1 diabetes gives rise to endothelial dysfunction, oxidative stress, and inflammation and GLP-1 can be useful to counterbalance these effects
McCluskey D, Touger MS, Melis R, et al

[DOI] [PubMed] [Google Scholar] 23.Lincoff A.M., Brown-Frandsen K., Colhoun H.M., Deanfield J., Emerson S.S., Esbjerg S., et al